News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,609 Results
Type
Article (32044)
Company Profile (59)
Press Release (365506)
Multimedia
Podcasts (41)
Webinars (5)
Section
Business (112872)
Career Advice (1322)
Deals (24060)
Drug Delivery (94)
Drug Development (59738)
Employer Resources (104)
FDA (9949)
Job Trends (9090)
News (211633)
Policy (25531)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1843)
Accelerated approval (4)
Adcomms (20)
Allergies (66)
Alliances (42289)
ALS (59)
Alzheimer's disease (1104)
Antibody-drug conjugate (ADC) (91)
Approvals (9945)
Artificial intelligence (156)
Autoimmune disease (16)
Automation (6)
Bankruptcy (237)
Best Places to Work (7697)
BIOSECURE Act (15)
Biosimilars (82)
Biotechnology (43)
Bladder cancer (46)
Brain cancer (27)
Breast cancer (181)
Cancer (1555)
Cardiovascular disease (125)
Career advice (1112)
Career pathing (19)
CAR-T (103)
Cell therapy (288)
Cervical cancer (16)
Clinical research (48195)
Collaboration (664)
Compensation (420)
Complete response letters (19)
COVID-19 (2475)
CRISPR (30)
C-suite (111)
Cystic fibrosis (59)
Data (1482)
Decentralized trials (1)
Denatured (9)
Depression (35)
Diabetes (212)
Diagnostics (3562)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (33)
Drug discovery (86)
Drug pricing (95)
Drug shortages (28)
Duchenne muscular dystrophy (82)
Earnings (40332)
Editorial (36)
Employer branding (13)
Employer resources (94)
Events (45738)
Executive appointments (311)
FDA (10777)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (467)
Gene editing (73)
Generative AI (13)
Gene therapy (229)
GLP-1 (688)
Government (4096)
Grass and pollen (4)
Guidances (35)
Healthcare (11419)
Huntington's disease (19)
IgA nephropathy (21)
Immunology and inflammation (84)
Indications (21)
Infectious disease (2614)
Inflammatory bowel disease (76)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (70)
Interviews (231)
IPO (10446)
IRA (41)
Job creations (1747)
Job search strategy (956)
Kidney cancer (7)
Labor market (16)
Layoffs (278)
Leadership (8)
Legal (7059)
Liver cancer (51)
Lung cancer (227)
Lymphoma (105)
Machine learning (5)
Management (32)
Manufacturing (213)
MASH (53)
Medical device (5927)
Medtech (5928)
Mergers & acquisitions (14015)
Metabolic disorders (584)
Multiple sclerosis (52)
NASH (20)
Neurodegenerative disease (68)
Neuropsychiatric disorders (22)
Neuroscience (1487)
NextGen: Class of 2025 (3658)
Non-profit (2770)
Northern California (1595)
Now hiring (5)
Obesity (334)
Opinion (192)
Ovarian cancer (53)
Pain (48)
Pancreatic cancer (65)
Parkinson's disease (113)
Partnered (13)
Patents (159)
Patient recruitment (57)
Peanut (38)
People (24895)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase I (14573)
Phase II (20936)
Phase III (16981)
Pipeline (871)
Policy (126)
Postmarket research (1846)
Preclinical (6030)
Press Release (28)
Prostate cancer (76)
Psychedelics (29)
Radiopharmaceuticals (204)
Rare diseases (267)
Real estate (2583)
Recruiting (44)
Regulatory (16120)
Reports (22)
Research institute (1592)
Resumes & cover letters (195)
Rett syndrome (3)
RNA editing (3)
RSV (47)
Schizophrenia (59)
Series A (76)
Series B (40)
Service/supplier (4)
Sickle cell disease (38)
Southern California (1307)
Special edition (5)
Spinal muscular atrophy (137)
Sponsored (18)
Startups (1890)
State (1)
Stomach cancer (11)
Supply chain (52)
Tariffs (20)
The Weekly (31)
United States (13006)
Vaccines (701)
Venture capitalists (25)
Weight loss (247)
Women's health (13)
Worklife (10)
Date
Today (15)
Last 7 days (297)
Last 30 days (1569)
Last 365 days (21081)
2025 (5964)
2024 (22381)
2023 (25291)
2022 (33419)
2021 (35906)
2020 (34083)
2019 (27924)
2018 (21245)
2017 (20194)
2016 (18693)
2015 (21496)
2014 (15948)
2013 (12878)
2012 (13623)
2011 (14401)
2010 (13079)
Location
Africa (570)
Alabama (30)
Alaska (3)
Arizona (90)
Arkansas (5)
Asia (25909)
Australia (4676)
California (3483)
Canada (1198)
China (347)
Colorado (148)
Connecticut (155)
Delaware (98)
Europe (62212)
Florida (532)
Georgia (125)
Hawaii (1)
Idaho (28)
Illinois (283)
India (22)
Indiana (187)
Iowa (6)
Japan (116)
Kansas (61)
Kentucky (15)
Louisiana (9)
Maine (28)
Maryland (634)
Massachusetts (2510)
Michigan (101)
Minnesota (138)
Mississippi (1)
Missouri (49)
Montana (20)
Nebraska (10)
Nevada (36)
New Hampshire (20)
New Jersey (1117)
New Mexico (15)
New York (1055)
North Carolina (498)
North Dakota (4)
Northern California (1595)
Ohio (110)
Oklahoma (6)
Oregon (10)
Pennsylvania (764)
Puerto Rico (5)
Rhode Island (12)
South America (797)
South Carolina (10)
South Dakota (1)
Southern California (1307)
Tennessee (52)
Texas (432)
Utah (77)
Virginia (88)
Washington D.C. (36)
Washington State (296)
West Virginia (2)
Wisconsin (27)
397,609 Results for "evotec ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
April 10, 2025
·
3 min read
Press Releases
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
April 17, 2025
·
7 min read
Collaboration
Novo, Evotec Ink Stem Cell Partnership as Drugmaker Looks to Expand Pipeline
While the companies did not reveal the financial details of the deal, Novo Nordisk will provide funding for two Evotec sites in Germany and Italy to support the development of next-generation cell therapies.
September 26, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
March 4, 2025
·
4 min read
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
Glycotope GmbH has signed an agreement with Evotec SE to combine Glycotope’s antibodies with Evotec’s immune cell engager platform for the development of next generation immune cell engaging bispecifics by Evotec.
December 11, 2023
·
3 min read
Press Releases
Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior Partner
February 19, 2025
·
2 min read
Business
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Evotec SE announced that the Company has reached important scientific progress within its neuroscience collaboration with Bristol Myers Squibb triggering a research payment of US$ 20 m to Evotec.
June 12, 2024
·
4 min read
Policy
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., was selected by the U.S. Department of Defense to develop an accelerated monoclonal antibody development and manufacturing solution for the DOD’s Manufacturing Optimization Program.
June 25, 2024
·
7 min read
Business
Evotec Reports Q1 2024 Results and Provides Corporate Update
Evotec SE announced financial results and corporate updates for the first quarter 2024.
May 22, 2024
·
14 min read
Press Releases
Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases
January 22, 2025
·
6 min read
1 of 39,761
Next
